Table: OncoTherapy Science -Q1 group results

OncoTherapy Science

07/08/2026 09:00

    Aug 7 (Reuters)- 
             OncoTherapy Science Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2026        Jun 30, 2025     Mar 31, 2027 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            170 mln             201 mln                    
                 (-15.2 pct)        (+100.1 pct)                  
  Operating     loss 285 mln        loss 303 mln                  
  Recurring     loss 287 mln        loss 313 mln                  
  Net           loss 288 mln        loss 314 mln                  
  EPS           loss 0.72 yen       loss 1.13 yen                 
  Ann Div                                NIL              NIL     
  -Q2 div
  -Q4 div                                NIL              NIL     
  
  NOTE - OncoTherapy Science Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4564.T